Edwards Lifesciences affirms its outlook for 2014 and reveals its 2015 guidance, along with an increased investment in CardioKinetix and a new leader for its critical care business lured from Medtronic.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uaaFoq
Cap comentari:
Publica un comentari a l'entrada